Medicare Enrolled
Brittney Atheras
Nurse Practitioner - Family · Freehold, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Atheras from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Atheras?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Atheras
Brittney Atheras is a nurse practitioner - family in Freehold, NJ, with 6 years of NPI registration. Based on federal Medicare data, Atheras performed 1,644 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Atheras received a total of $6,914 from 64 pharmaceutical and/or device companies across 427 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Atheras is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 6 years of NPI registration
▲ Top 7% volume in NJ
$6,914 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,644
Medicare services
Top 7% in NJ for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
600 | $6 | $55 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
380 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
123 | $21 | $152 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
122 | $8 | $19 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
98 | $8 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $64 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $10 | $93 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
45 | $1 | $18 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
37 | $1 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
35 | $98 | $686 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $92 | $226 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
19 | $11 | $105 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
13 | $48 | $304 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
10.4% high complexity
66.4% medium
23.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,914
Total received (2021-2024)
Avg $1,729/year across 4 years
Top 2% in NJ for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
427
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,529
2023
$2,533
2022
$1,832
2021
$1,020
Payments by company (2024)
Daiichi Sankyo Inc.
$199
Gilead Sciences, Inc.
$178
ABBVIE INC.
$153
Novartis Pharmaceuticals Corporation
$144
Ipsen Biopharmaceuticals, Inc
$70
Bayer Healthcare Pharmaceuticals Inc.
$66
Eisai Inc.
$59
GlaxoSmithKline, LLC.
$57
AstraZeneca Pharmaceuticals LP
$48
Celgene Corporation
$47
Incyte Corporation
$46
Merck Sharp & Dohme LLC
$45
Astellas Pharma US Inc
$44
Janssen Biotech, Inc.
$38
Rigel Pharmaceuticals, Inc.
$38
SERVIER PHARMACEUTICALS LLC
$37
PUMA BIOTECHNOLOGY, INC.
$33
Mirati Therapeutics, Inc.
$33
ADC Therapeutics America, Inc.
$21
Genentech USA, Inc.
$20
Karyopharm Therapeutics Inc.
$18
Pharmacosmos Therapeutics Inc.
$17
PFIZER INC.
$17
Lilly USA, LLC
$16
Myriad Genetic Laboratories, Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
ImmunoGen, Inc.
$14
Coherus Biosciences Inc.
$14
EMD Serono, Inc.
$14
AIMMUNE THERAPEUTICS, INC.
$14
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2021-2024) ›
Daiichi Sankyo Inc.
$469
Gilead Sciences, Inc.
$446
Merck Sharp & Dohme LLC
$428
Astellas Pharma US Inc
$342
Seagen Inc.
$332
Amgen Inc.
$320
Novartis Pharmaceuticals Corporation
$292
AstraZeneca Pharmaceuticals LP
$281
Janssen Biotech, Inc.
$273
ABBVIE INC.
$215
Incyte Corporation
$211
Bayer Healthcare Pharmaceuticals Inc.
$204
Eisai Inc.
$195
GlaxoSmithKline, LLC.
$149
Takeda Pharmaceuticals U.S.A., Inc.
$128
Lilly USA, LLC
$121
Karyopharm Therapeutics Inc.
$120
Celgene Corporation
$116
Pharmacosmos Therapeutics Inc.
$115
Bayer HealthCare Pharmaceuticals Inc.
$108
GENZYME CORPORATION
$106
Coherus Biosciences Inc.
$104
E.R. Squibb & Sons, L.L.C.
$95
SERVIER PHARMACEUTICALS LLC
$90
TAIHO ONCOLOGY, INC.
$89
Mirati Therapeutics, Inc.
$87
EISAI INC.
$85
G1 Therapeutics, Inc.
$83
Genentech USA, Inc.
$82
Foundation Medicine, Inc.
$82
PFIZER INC.
$81
Merck Sharp & Dohme Corporation
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
EMD Serono, Inc.
$70
Ipsen Biopharmaceuticals, Inc
$70
MorphoSys, US Inc.
$58
Dendreon Pharmaceuticals LLC
$51
Stemline Therapeutics Inc.
$51
PUMA BIOTECHNOLOGY, INC.
$48
AVEO Pharmaceuticals, Inc.
$42
Pharmacyclics LLC, An AbbVie Company
$42
Regeneron Healthcare Solutions, Inc.
$41
Rigel Pharmaceuticals, Inc.
$38
ARRAY BIOPHARMA INC
$34
Genmab U.S., Inc.
$32
Kyowa Kirin, Inc.
$31
Sobi, Inc
$30
ImmunoGen, Inc.
$28
JAZZ PHARMACEUTICALS INC.
$24
ADC Therapeutics America, Inc.
$21
SOBI, INC
$18
TerSera Therapeutics LLC
$17
Deciphera Pharmaceuticals Inc.
$17
Puma Biotechnology, Inc.
$16
Adaptive Biotechnologies Corporation
$15
Blueprint Medicines Corporation
$15
Myriad Genetic Laboratories, Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
AbbVie Inc.
$15
Servier Pharmaceuticals LLC
$14
BeiGene USA, Inc.
$14
Myovant Sciences Inc.
$14
AIMMUNE THERAPEUTICS, INC.
$14
Epizyme, Inc.,
$13
Top 3 companies account for 19.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BRAFTOVI · BRUKINSA · Blincyto · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELZONRIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Enhertu · FOTIVDA · FOUNDATIONONE CDX · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · MYRISK · Monoferric · NERLYNX · NINLARO · Nplate · Nubeqa · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SCEMBLIX · Stivarga · TAZVERIK · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tibsovo · Tivdak · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VPRIV · Vanflyta · Venclexta · Vitrakvi · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZENPEP · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
1,077
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
CENTRASTATE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Atheras is a mixed practice specialist, with above-average Medicare volume (top 7% in NJ).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Atheras experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Atheras performed 600 epoetin alfa injection (procrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Atheras receive payments from pharmaceutical companies?
Yes. Atheras received a total of $6,914 from 64 companies across 427 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Atheras's costs compare to other family nurse practitioners in Freehold?
Atheras's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Atheras) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Freehold
Browse family nurse practitioners in Freehold ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in NJ
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in NJ
Which NJ family nurse practitioners receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology